Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

7.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of Cochlear Implantation on Listening-Related Fatigue in Children With Unilateral Hearing Loss.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026
Same author

Silk-Hyaluronic Acid Laryngoplasty Outcomes: An Independent Tertiary Center Experience.

The Laryngoscope·2026
Same author

Occupational, Environmental, and Irritant-induced Cough.

Otolaryngologic clinics of North America·2026
Same author

Longitudinal Cochlear Implant Use in Pediatric Patients With Unilateral Hearing Loss.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

T cell-intrinsic VISTA expression promotes resistance to CTLA-4 blockade by restricting CD8+ T cell responses.

The Journal of clinical investigation·2026
Same author

Transoral Minimal Access Mandibular Reconstruction Using Fibula Free Flap in Osteoradionecrosis.

The Laryngoscope·2026

相关实验视频

Updated: Jan 6, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

760

甲状腺手术和潜在解决方案的报销.

Philip R Brauer1, David Octeau1, Benjamin Wajsberg1

  • 1Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio.

JAMA otolaryngology-- head & neck surgery
|October 16, 2025
PubMed
概括

自2000年以来,甲状腺手术的医疗保险补偿金已大幅下降近40%,影响全甲状腺切除率最大. 这些不可持续的趋势需要采取主动措施,确保患者获得甲状腺外科护理.

更多相关视频

A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery
04:42

A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery

Published on: February 17, 2023

1.7K
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

4.6K

相关实验视频

Last Updated: Jan 6, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

760
A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery
04:42

A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery

Published on: February 17, 2023

1.7K
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

4.6K

科学领域:

  • 卫生经济学 卫生经济学
  • 外科手术报销分析
  • 医疗保险政策 医疗保险政策

背景情况:

  • 医疗保险支付模式正在进行改革讨论,这在2024年美国参议院财政委员会白皮书中得到了强调.
  • 了解历史退款趋势对于为未来的医疗保险支付改革提供信息至关重要.

研究的目的:

  • 分析医疗保险从2000年到2023年为甲状腺手术补偿的趋势.
  • 为正在进行的医疗保险支付改革讨论提供经济证据.

主要方法:

  • 以医疗保险和医疗补助服务中心的医生费用表数据 (2000-2023) 进行回顾性经济评估.
  • 经通胀调整后的报销数据为2023年美元.
  • 分析国家平均退款,复合年增长率和皮尔森相关系数.

主要成果:

  • 在通货膨胀调整后,甲状腺手术的医疗保险补偿金下降了38.7% (1517.59美元至929.55美元).
  • 甲状腺切除术总赔偿金出现了最大的下降 (47.8%,1803.16美元至942.07美元).
  • 经通货膨胀调整后的复合年增长率为-2.1%,在2012-2023年期间,劳动相对价值单位的增长为零.

结论:

  • 甲状腺手术报销率的显著下降,特别是对于全甲状腺切除术,表明了不可持续的趋势.
  • 目前的报销趋势可能会影响患者获得关键的甲状腺外科手术程序.
  • 甲状腺外科医生应该主动解决报销挑战,以保持获得护理的机会.